SEC Form 4 · accession 0001209191-15-070520
Inogen Inc · INGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matt Scribner
Officer — EVP, Operations
Period of report
Sep 10, 2015
Accepted (ET)
Sep 14, 2015 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001294133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 10, 2015 | M | 4,102 | $0.60 | A | 8,768 | D | |
| Common StockF2 | Sep 10, 2015 | S | 3,902 | $53.2714 | D | 4,866 | D | |
| Common StockF3 | Sep 10, 2015 | S | 200 | $53.765 | D | 4,666 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $0.60 | Sep 10, 2015 | M | 4,102 | D | — | Feb 24, 2020 | Common Stock | 4,102 | 9,888 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2015.
- F2Represents the weighted average share price of an aggregate total of 3,902 shares sold in the price range of $52.75 to $53.74 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Represents the weighted average share price of an aggregate total of 200 shares sold in the price range of $53.76 to $53.77 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4Subject to the reporting person's continuing service, thirty-nine percent (39%) of the shares subject to the option shall vest and become exercisable on the vesting commencement date, and thereafter, one thirtieth (1/30th) of the remaining shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the thirty (30) month anniversary of the vesting commencement date. The vesting commencement date for this option is February 24, 2010.